Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Obalon Therapeutics Inc    OBLN

OBALON THERAPEUTICS INC (OBLN)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/12/2018 01/16/2018 01/17/2018 01/18/2018 01/19/2018 Date
7.9(c) 7.93(c) 6.865(c) 6.14(c) 5.24(c) Last
57 176 50 615 354 586 371 616 3 193 429 Volume
+0.38% +0.38% -13.43% -10.56% -14.66% Change
More quotes
Financials ($)
Sales 2017 10,0 M
EBIT 2017 -32,3 M
Net income 2017 -31,9 M
Finance 2017 29,0 M
Yield 2017 -
Sales 2018 22,2 M
EBIT 2018 -29,4 M
Net income 2018 -29,7 M
Finance 2018 5,73 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 6,23x
EV / Sales2018 3,86x
Capitalization 91,4 M
More Financials
Company
Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then... 
More about the company
Surperformance© ratings of Obalon Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on OBALON THERAPEUTICS INC
01/19 Obalon Therapeutics Prices Public Offering of Common Stock
01/17 OBALON THERAPEUTICS : Announces Proposed Public Offering of Common Stock
01/16 Obalon Therapeutics Announces Proposed Public Offering of Common Stock
01/05 OBALON THERAPEUTICS, INC. (NASDAQ : OBLN) Files An 8-K Results of Operations and..
01/05 OBALON THERAPEUTICS INC : Results of Operations and Financial Condition, Financi..
01/05 Obalon Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter a..
01/04 OBALON SCHEDULES FOURTH QUARTER AND : 30 a.m. Eastern Time
2017 OBALON THERAPEUTICS, INC. (NASDAQ : OBLN) Files An 8-K Departure of Directors or..
2017 OBALON THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K)
2017 Obalon Announces Upcoming Conference Presentations
More news
Sector news : Medical Devices & Implants
01/12 China cracks down on foreign companies calling Taiwan, other regions countrie..
01/12 China cracks down on foreign companies calling Taiwan, other regions countrie..
01/12 Delta, Zara and Medtronic Join Marriott in Beijing's Doghouse After Location ..
01/08 MALLINCKRODT : to Sell Two Hemostasis Products to Baxter
01/07 BAXTER INTERNATIONAL : Hospitals Wrestle With Shortage of IV Bags, Linked to Hur..
More sector news : Medical Devices & Implants
Latest Tweets
01/19On The Fly: Pre-market Movers $EMAN $MLNX $CFG $RF $STI $FB $ANF $NKE $GDEN $..
1
01/19$OBLN (-9.6% pre) Obalon Therapeutics Prices 5.45m Share Common Offering at $.. 
01/19Obalon prices stock offering at $5.50; shares down 6% premarket  
01/19$OBLN: Obalon Therapeutics prices offering of 5,454,545 shares of $5.50 per s..
1
01/19BRIEF-Obalon Therapeutics prices offering of 5.5 mln shares at $5.50 per shar.. 
More tweets
Qtime:21
News from SeekingAlpha
01/19 Obalon prices stock offering at $5.50; shares down 6% premarket
01/16 Obalon readies IPO
01/05 Obalon Therapeutics' (OBLN) CEO Andrew Rasdal on Q4 2017 Results - Earnings C..
01/05 Obalon Therapeutics reports preliminary Q4 revenue
2017 Analyst action - healthcare
Chart OBALON THERAPEUTICS INC
Duration : Period :
Obalon Therapeutics Inc Technical Analysis Chart | OBLN | US67424L1008 | 4-Traders
Technical analysis trends OBALON THERAPEUTICS INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 12,8 $
Spread / Average Target 144%
EPS Revisions
Managers
NameTitle
Andrew P. Rasdal President, Chief Executive Officer & Director
Kim P. Kamdar Chairman
Kelly Huang Chief Operating Officer
William John Plovanic Chief Financial Officer & Secretary
Mark Brister Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
OBALON THERAPEUTICS INC-7.11%91
STRYKER CORPORATION3.51%60 357
SMITH & NEPHEW-4.46%15 136
WRIGHT MEDICAL GROUP NV2.25%2 422
JAPAN LIFELINE CO., LTD.8.96%2 105
GLAUKOS CORP15.48%986